SELECT MED HLDGS CORP's ticker is SEM and the CUSIP is 81619Q105. A total of 267 filers reported holding SELECT MED HLDGS CORP in Q2 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,996,921 | -27.5% | 118,596 | -8.6% | 0.01% | -16.7% |
Q2 2023 | $4,132,720 | +19.7% | 129,715 | -2.9% | 0.01% | +20.0% |
Q1 2023 | $3,452,629 | +3.2% | 133,564 | -0.8% | 0.01% | 0.0% |
Q4 2022 | $3,344,527 | +10.6% | 134,697 | -1.5% | 0.01% | 0.0% |
Q3 2022 | $3,023,000 | -10.8% | 136,794 | -4.6% | 0.01% | 0.0% |
Q2 2022 | $3,388,000 | +2.3% | 143,423 | +3.9% | 0.01% | +25.0% |
Q1 2022 | $3,311,000 | -25.7% | 138,005 | -8.9% | 0.00% | -20.0% |
Q4 2021 | $4,455,000 | -16.8% | 151,541 | +2.4% | 0.01% | -28.6% |
Q3 2021 | $5,352,000 | -16.8% | 147,961 | -2.9% | 0.01% | -12.5% |
Q2 2021 | $6,436,000 | +15.2% | 152,307 | -7.0% | 0.01% | +14.3% |
Q1 2021 | $5,585,000 | +22.8% | 163,789 | -0.4% | 0.01% | +16.7% |
Q4 2020 | $4,548,000 | +32.7% | 164,434 | -0.1% | 0.01% | 0.0% |
Q3 2020 | $3,427,000 | +42.1% | 164,587 | +0.5% | 0.01% | +50.0% |
Q2 2020 | $2,412,000 | -3.8% | 163,769 | -2.1% | 0.00% | -20.0% |
Q1 2020 | $2,508,000 | -36.1% | 167,220 | -0.5% | 0.01% | -28.6% |
Q4 2019 | $3,922,000 | +38.0% | 168,048 | -2.0% | 0.01% | +16.7% |
Q3 2019 | $2,841,000 | +5.7% | 171,443 | +1.2% | 0.01% | +20.0% |
Q2 2019 | $2,688,000 | +14.9% | 169,395 | +2.0% | 0.01% | 0.0% |
Q1 2019 | $2,339,000 | -11.1% | 166,034 | -3.1% | 0.01% | -16.7% |
Q4 2018 | $2,630,000 | -13.9% | 171,360 | +3.3% | 0.01% | 0.0% |
Q3 2018 | $3,053,000 | +0.3% | 165,948 | -1.0% | 0.01% | 0.0% |
Q2 2018 | $3,043,000 | +7.8% | 167,672 | +2.5% | 0.01% | 0.0% |
Q1 2018 | $2,822,000 | -5.6% | 163,596 | -3.4% | 0.01% | 0.0% |
Q4 2017 | $2,989,000 | -9.5% | 169,332 | -1.6% | 0.01% | -14.3% |
Q3 2017 | $3,302,000 | +13.0% | 171,998 | -9.6% | 0.01% | +16.7% |
Q2 2017 | $2,922,000 | +4.1% | 190,343 | -9.5% | 0.01% | 0.0% |
Q1 2017 | $2,807,000 | -3.8% | 210,269 | -4.5% | 0.01% | 0.0% |
Q4 2016 | $2,917,000 | -4.4% | 220,169 | -2.6% | 0.01% | 0.0% |
Q3 2016 | $3,051,000 | +25.4% | 225,969 | +0.9% | 0.01% | +20.0% |
Q2 2016 | $2,433,000 | -74.2% | 223,869 | -72.0% | 0.01% | -75.0% |
Q1 2016 | $9,433,000 | -33.8% | 798,750 | -33.2% | 0.02% | -42.9% |
Q4 2015 | $14,247,000 | -4.6% | 1,196,230 | -13.6% | 0.04% | -10.3% |
Q3 2015 | $14,940,000 | -28.9% | 1,384,625 | +6.8% | 0.04% | -23.5% |
Q2 2015 | $21,007,000 | +2.1% | 1,296,740 | -6.5% | 0.05% | +4.1% |
Q1 2015 | $20,573,000 | -13.5% | 1,387,257 | -16.0% | 0.05% | -12.5% |
Q4 2014 | $23,776,000 | +19.7% | 1,651,077 | +0.0% | 0.06% | +14.3% |
Q3 2014 | $19,855,000 | -36.3% | 1,650,456 | -17.4% | 0.05% | -37.2% |
Q2 2014 | $31,180,000 | -10.3% | 1,998,731 | -28.4% | 0.08% | -15.2% |
Q1 2014 | $34,778,000 | +7.3% | 2,793,431 | +0.0% | 0.09% | +4.5% |
Q4 2013 | $32,427,000 | +16.4% | 2,793,031 | -19.1% | 0.09% | +6.0% |
Q3 2013 | $27,850,000 | +3.2% | 3,451,064 | +21.2% | 0.08% | -5.7% |
Q2 2013 | $26,995,000 | +1.7% | 2,846,541 | +2.1% | 0.09% | -1.1% |
Q1 2013 | $26,554,000 | – | 2,786,835 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Standard LLC | 213,703 | $5,524,223 | 5.60% |
Camber Capital Management LP | 4,800,000 | $124,080 | 3.82% |
Hood River Capital Management LLC | 2,693,137 | $69,618,000 | 2.25% |
Smith, Graham & Co., Investment Advisors, LP | 434,878 | $11,241,596 | 1.37% |
Sivik Global Healthcare LLC | 107,838 | $2,788 | 1.20% |
Capital Impact Advisors, LLC | 33,173 | $857,522 | 1.05% |
DENALI ADVISORS LLC | 85,772 | $2,217,206 | 0.92% |
CLOUGH CAPITAL PARTNERS L P | 297,500 | $7,690,375 | 0.83% |
Huber Capital Management LLC | 127,603 | $3,298,537 | 0.82% |
Nebula Research & Development LLC | 12,442 | $321,626 | 0.57% |